8.50
-0.45
(-5.06%)
At close: April 11 at 9:09:34 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 13 | 19 | 19 |
| Avg. Estimate | 12.56B | 14.6B | 55.71B | 58.81B |
| Low Estimate | 12.31B | 13.83B | 53B | 56.93B |
| High Estimate | 12.81B | 14.91B | 57.19B | 60.31B |
| Year Ago Sales | 12.57B | 14.33B | 54.21B | 55.71B |
| Sales Growth (year/est) | -0.09% | 1.86% | 2.76% | 5.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| A1G.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/8/2025 |
| Downgrade | Goldman Sachs: Neutral to Sell | 4/8/2025 |
| Maintains | UBS: Neutral to Neutral | 4/7/2025 |
| Maintains | Susquehanna: Neutral to Neutral | 4/7/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 4/3/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/2/2025 |